Trials / Completed
CompletedNCT01888120
Patient Registry of Intrathecal Ziconotide Management(PRIZM)
Patient Registry of Intrathecal Ziconotide Management (PRIZM): An Open-Label, Long Term, Multi-Center, Observational Study of PRIALT® (Ziconotide) Solution, Intrathecal Infusion, in Patients With Severe Chronic Pain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 93 (actual)
- Sponsor
- Jazz Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the effectiveness, long-term safety, tolerability, satisfaction with treatment, and health-related quality of life (HRQoL) associated with Intrathecal PRIALT use for severe chronic pain of varying etiologies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ziconotide |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2017-01-01
- Completion
- 2017-03-01
- First posted
- 2013-06-27
- Last updated
- 2017-03-16
Locations
43 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01888120. Inclusion in this directory is not an endorsement.